Rallybio Corporation (RLYB) earnings
RLYB earnings moved a median of -0.09% by the close. Quarterly and annual RLYB reports and results, each read against the price at its own news timestamp. Back to the RLYB overview →
20 measured RLYB earnings events.
Where these RLYB earnings landedvs 20 measured RLYB earnings reactions
| Middle 50% of RLYB earnings reactions | -0.92% to +1.03% |
|---|---|
| Median reaction (to close) | -0.09% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 RLYB earnings events with a measured close landed between -0.92% and +1.03%; 40% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Rallybio Corp For: Jun 30 | SEC filing · Form 10-Q | — | -0.31% | |
| Form 10-Q Rallybio Corp For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -1.18% | |
| Form 10-K Rallybio Corp For: Dec 31 | SEC filing · Form 10-K | +1.19% | +4.66% | |
| Form 10-Q Rallybio Corp For: Sep 30 | SEC filing · Form 10-Q | +2.58% | +2.17% | |
| Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates | Press release | +2.58% | +2.17% | |
| Form 10-Q Rallybio Corp For: Jun 30 | SEC filing · Form 10-Q | -2.36% | -0.18% | |
| Rallybio Reports Second Quarter 2025 Financial Results and Provides Business Updates | Press release | -2.36% | -0.18% | |
| Form 10-Q Rallybio Corp For: Mar 31 | SEC filing · Form 10-Q | +6.90% | +1.03% | |
| Rallybio Reports First Quarter 2025 Financial Results and Provides Business Updates | Press release | +6.90% | +1.03% | |
| Form 10-K Rallybio Corp For: Dec 31 | SEC filing · Form 10-K | +0.48% | -1.56% | |
| Rallybio to Initiate RLYB116 Confirmatory Clinical PK/PD Study in Second Quarter 2025 | Press release | -3.02% | -3.42% | |
| Form 10-Q Rallybio Corp For: Sep 30 | SEC filing · Form 10-Q | +1.01% | +1.01% | |
| Rallybio Reports Third Quarter 2024 Financial Results and Provides Business Updates | Press release | +4.04% | +0.00% | |
| Form 10-Q Rallybio Corp For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -0.83% | |
| Rallybio Reports Second Quarter 2024 Financial Results and Provides Business Updates | Press release | +0.00% | -0.83% | |
| Form 10-Q Rallybio Corp For: Mar 31 | SEC filing · Form 10-Q | -0.26% | -5.67% | |
| Rallybio Reports First Quarter 2024 Financial Results and Provides Business Updates | Press release | -0.53% | +0.00% | |
| Form 10-K Rallybio Corp For: Dec 31 | SEC filing · Form 10-K | +2.05% | +2.63% | |
| Form 10-Q Rallybio Corp For: Sep 30 | SEC filing · Form 10-Q | -1.65% | -5.28% | |
| Rallybio Reports Third Quarter 2023 Financial Results and Provides Business Updates | Press release | +0.00% | +1.00% |
Keep exploring
More RLYB: analyst actions → · SEC filings → · RLYB overview →